Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04531657 · ClinicalTrials.gov registry record
Influenza Vaccine in Lung Transplant Patients - Seroprotection
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 79
- Enrollment target
NCT04531657: Completed study, sponsored by University of Wisconsin, Madison.
NCT04531657 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04531657 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This study is designed to investigate two different definitions of influenza vaccine seroprotection at mid-season in lung transplant patients.
Primary Outcome
The hypothesis is that seroprotection, defined as 40 HAU or greater, will persist up to 6 months at high rates in lung transplant patients and that these rates will be comparable to the rates in healthy individuals. Seroprotection (antibody titer greater than or equal to 1:40) will be reported for H1N1, H3N2, and B viral antigens.
Interventions
- DRUG Influenza vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2004-12 |
| Est. Completion | 2009-07 |
What the finished NCT04531657 record still lists
NCT04531657 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 79 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Influenza vaccine is the first listed.
NCT04531657 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04531657 about?
NCT04531657 is a clinical study titled "Influenza Vaccine in Lung Transplant Patients - Seroprotection". This a sub-study of a 5-year study designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healthy individuals. This study is designed to investigate two different definitions of inf...
What is the current status of trial NCT04531657?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2004-12. Estimated completion is 2009-07.
What interventions are being tested in trial NCT04531657?
The interventions under investigation include: Influenza vaccine (DRUG).
Who is sponsoring clinical trial NCT04531657?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia